Innovative Medicines Initiative Provides 246 Million Euros To Support Public-private Research Cooperation For The Faster Development Of Innovative Med
Today, fifteen new research projects aimed at bringing innovative medicines to market faster have been selected to receive 246 million Euros from the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA), of which the Irish Pharmaceutical Healthcare Association (IPHA) is a member. The projects will foster understanding of health issues such as diabetes, pain, severe asthma and psychiatric disorders while increasing medicine safety. They will also help improve the training of researchers and clinicians involved in medicines development. The projects were chosen following the first call for proposals launched within the Innovative Medicines Initiative (IMI), a public-private partnership - so called Joint Technology Initiative - between the European Commission and the pharmaceutical industry.
Cardiovascular